Evaluation of CYP3A‐mediated drug–drug interactions with romidepsin in patients with advanced cancer

E-ISSN： 1552-4604|55|12|1378-1385

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.12, 2015-12, pp. : 1378-1385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug‐Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Analysis

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 2, 2018-02 ,pp. : 180-192

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Potential Drug–Drug Interactions of Ginkgolide B Mediated by Renal Transporters

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 5, 2015-05 ,pp. : 662-667

John Wiley & Sons Inc

Access to resources Recommend Favorite

Romidepsin Overcomes Cell Adhesion-Mediated Drug Resistance in Multiple Myeloma Cells

Acta Haematologica, Vol. 132, Iss. 1, 2013-12 ,pp. : 1-4

Karger

Access to resources Recommend Favorite

In Vitro Prediction of Clinical Drug Interactions With CYP3A Substrates: We Are Not There Yet

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 95, Iss. 2, 2014-02 ,pp. : 133-135

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Nanogram Dose of the CYP3A Probe Substrate Midazolam to Evaluate Drug Interactions

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 6, 2013-06 ,pp. : 564-571

John Wiley & Sons Inc

Access to resources Recommend Favorite